RVP Quote, Financials, Valuation and Earnings

InfuSystems Holdings has a net margin of -18.58% compared to Retractable Technologies's net margin of 2.76%. Retractable Technologies's return on equity of -16.83% beat InfuSystems Holdings's return on equity of 4.33%.

Retractable Technologies has a consensus price target of --, signalling downside risk potential of --. On the other hand InfuSystems Holdings has an analysts' consensus of $14.13 which suggests that it could grow by 163.53%. Given that InfuSystems Holdings has higher upside potential than Retractable Technologies, analysts believe InfuSystems Holdings is more attractive than Retractable Technologies.

Retractable Technologies has a beta of 2.279, which suggesting that the stock is 127.852% more volatile than S&P 500. In comparison InfuSystems Holdings has a beta of 1.898, suggesting its more volatile than the S&P 500 by 89.81%.

Retractable Technologies has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. InfuSystems Holdings offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Retractable Technologies pays -3.32% of its earnings as a dividend. InfuSystems Holdings pays out -- of its earnings as a dividend.

Retractable Technologies quarterly revenues are $10.3M, which are smaller than InfuSystems Holdings quarterly revenues of $33.8M. Retractable Technologies's net income of -$1.9M is lower than InfuSystems Holdings's net income of $933K. Notably, Retractable Technologies's price-to-earnings ratio is -- while InfuSystems Holdings's PE ratio is 53.60x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Retractable Technologies is 0.56x versus 0.86x for InfuSystems Holdings. Usually stocks with elevated PS ratios are considered overvalued.

VolitionRX has a net margin of -18.58% compared to Retractable Technologies's net margin of -1226.82%. Retractable Technologies's return on equity of -16.83% beat VolitionRX's return on equity of --.

Retractable Technologies has a consensus price target of --, signalling downside risk potential of --. On the other hand VolitionRX has an analysts' consensus of $3.37 which suggests that it could grow by 550.47%. Given that VolitionRX has higher upside potential than Retractable Technologies, analysts believe VolitionRX is more attractive than Retractable Technologies.

Retractable Technologies has a beta of 2.279, which suggesting that the stock is 127.852% more volatile than S&P 500. In comparison VolitionRX has a beta of 1.155, suggesting its more volatile than the S&P 500 by 15.463%.

Retractable Technologies has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. VolitionRX offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Retractable Technologies pays -3.32% of its earnings as a dividend. VolitionRX pays out -- of its earnings as a dividend.

Retractable Technologies quarterly revenues are $10.3M, which are larger than VolitionRX quarterly revenues of $474.5K. Retractable Technologies's net income of -$1.9M is higher than VolitionRX's net income of -$5.8M. Notably, Retractable Technologies's price-to-earnings ratio is -- while VolitionRX's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Retractable Technologies is 0.56x versus 33.47x for VolitionRX. Usually stocks with elevated PS ratios are considered overvalued.

Catheter Precision has a net margin of -18.58% compared to Retractable Technologies's net margin of -4291.67%. Retractable Technologies's return on equity of -16.83% beat Catheter Precision's return on equity of -65.84%.

Retractable Technologies has a consensus price target of --, signalling downside risk potential of --. On the other hand Catheter Precision has an analysts' consensus of -- which suggests that it could grow by 473.07%. Given that Catheter Precision has higher upside potential than Retractable Technologies, analysts believe Catheter Precision is more attractive than Retractable Technologies.

Retractable Technologies has a beta of 2.279, which suggesting that the stock is 127.852% more volatile than S&P 500. In comparison Catheter Precision has a beta of -0.775, suggesting its less volatile than the S&P 500 by 177.508%.

Retractable Technologies has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Catheter Precision offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Retractable Technologies pays -3.32% of its earnings as a dividend. Catheter Precision pays out -- of its earnings as a dividend.

Retractable Technologies quarterly revenues are $10.3M, which are larger than Catheter Precision quarterly revenues of $96K. Retractable Technologies's net income of -$1.9M is higher than Catheter Precision's net income of -$4.1M. Notably, Retractable Technologies's price-to-earnings ratio is -- while Catheter Precision's PE ratio is 0.40x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Retractable Technologies is 0.56x versus 0.93x for Catheter Precision. Usually stocks with elevated PS ratios are considered overvalued.

Xtant Medical Holdings has a net margin of -18.58% compared to Retractable Technologies's net margin of -10.04%. Retractable Technologies's return on equity of -16.83% beat Xtant Medical Holdings's return on equity of -35.34%.

Retractable Technologies has a consensus price target of --, signalling downside risk potential of --. On the other hand Xtant Medical Holdings has an analysts' consensus of $1.75 which suggests that it could grow by 272.26%. Given that Xtant Medical Holdings has higher upside potential than Retractable Technologies, analysts believe Xtant Medical Holdings is more attractive than Retractable Technologies.

Retractable Technologies has a beta of 2.279, which suggesting that the stock is 127.852% more volatile than S&P 500. In comparison Xtant Medical Holdings has a beta of -0.033, suggesting its less volatile than the S&P 500 by 103.341%.

Retractable Technologies has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Xtant Medical Holdings offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Retractable Technologies pays -3.32% of its earnings as a dividend. Xtant Medical Holdings pays out -- of its earnings as a dividend.

Retractable Technologies quarterly revenues are $10.3M, which are smaller than Xtant Medical Holdings quarterly revenues of $31.5M. Retractable Technologies's net income of -$1.9M is higher than Xtant Medical Holdings's net income of -$3.2M. Notably, Retractable Technologies's price-to-earnings ratio is -- while Xtant Medical Holdings's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Retractable Technologies is 0.56x versus 0.54x for Xtant Medical Holdings. Usually stocks with elevated PS ratios are considered overvalued.